Pharma Jobs

bioCampus - a center of excellence is the training division of GVK BIO where training in Advanced bioinformatics, molecular modeling, drug discovery & design and cheminformatics skills would be imparted to professionals from related inter-disciplinary fields.

A Public Limited Company in the Business of Manufacturing & Marketing of APIs and Drug Intermediates with an Annual Turnover of about Rs.70 Crores with a significant presence in the international market.

Post: Research Associate

[adsense:336x280:8701650588]

Indian Rare Earths Limited (IREL) a Public Sector Undertaking under the administrative control of the Department of Atomic Energy is the industry leader in the area of Beach Sand Minerals like Ilmenite, Rutile (Titanium ores), Zircon, Monazite, Sillimanite etc. and producer of rare earth (Lanthanides) chemicals, Thorium Nitrate etc.

JIIT has been developed as a modern world class campus, with intellectually vibrant ambience in a serene and lush green environment. The state-of-the-art campus at a total project cost of Rs. 162 cores, with a total built up area of over 69623 sq.

Bristol-Myers Squibb Biocon R&D Center (BBRC) is a collaboration between Bristol-Myers Squibb and Syngene International, a subsidiary of the Indian biotechnology major, Biocon. This initiative is intended to help advance Bristol-Myers Squibb's work in discovery and early drug development. The center is expanding its capabilities to clinical biomarkers, toxicology and first-in-human studies.

The University Institute of Pharmaceutical Sciences of the Panjab University is a premier institution of Pharmaceutical Education and Research in the country. The institute has covered a long and glorious journey of 76 years starting from Lahore in 1944 and finally settling to the present campus in Chandigarh at the foothills of Himachal.

Biocon is a research-driven, global healthcare company with a strong matrix of capabilities along the biopharmaceutical value chain. Focusing on unmet medical needs in cancer, diabetes and inflammatory diseases, it offers novel therapies on a platform of affordable innovation.